Novartis AG
ANTIBODY MOLECULES TO CD73 AND USES THEREOF
Last updated:
Abstract:
Anti-CD73 antibody molecules and combination therapies thereof are disclosed. The antibody molecules and combination therapies disclosed herein can be used to treat or prevent cancer.
Status:
Application
Type:
Utility
Filling date:
21 Jun 2018
Issue date:
4 Jun 2020